GW Pharmaceuticals’ eye-watering price because of its brand brand new CBD medication might travel (temporarily) into the U.S., but in European countries, competition is being motivated.
Share this:
In an amazing August that is early conference with Seeking Alpha, British-based GW Pharmaceuticals finally revealed their retail price for CBD-based drug, Epidiolex, since it gets into circulation when you look at the U.S.
The medication is perfect for the treating specific types of childhood epilepsy – although only a few types. Also notable needless to say, is GW Pharma’s “other” drug for treatment of resistant epilepsy failed in belated stage studies in Eastern Europe earlier in the day this present year. (more…)